Cathepsin K in melanoma invasion

Journal of Investigative Dermatology

Volumn 128, Issue 9, 2008, Pages 2281-2288

  Quintanilla Dieck, Maria J ^a   Codriansky, Katerine ^a   Keady, Michelle ^a   Bhawan, Jag ^a   Rünger, Thomas M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K;

ARTICLE; CANCER CELL; CANCER INVASION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 49549102043     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.63     Document Type: Article

References (52)

1. Adami S, Supronik J, Hala T, Brown JP, Garnero P, Haemmerle S et al. (2006) Effect of one year treatment with the cathepsin-K inhibitor, balicatib, on bone mineral density (BMD) in postmenopausal women with osteopenia/osteoporosis (abstract). J Bone Miner Res 21(Suppl 1):S24
2. Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C et al. (1996) Proteolytic activity of human osteoclasts cathepsin K. J Biol Chem 271:12517-24
3. Bühling F, Röcken C, Brasch F, Hartig R, Yasuda Y, Saftig P et al. (2004) Pivotal role of cathepsin K in lung fibrosis. Am J Pathol 164:2203-16
4. Chapman HA, Riese RJ, Shi GP (1997) Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 59:63-88
5. Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295:2387-92
6. Curran S, Murray GI (1999) Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 189:300-8
7. Dennhofer R, Kurschat P, Zigrino P, Klose A, Bosserhoff A, van MG et al. (2003) Invasion of melanoma cells into dermal connective tissue in vitro: evidence for an important role of cysteine proteases. Int J Cancer 106:316-23
8. Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25:9-34
9. Dodds RA, James IE, Rieman D, Ahern R, Hwang SM, Connor JR et al. (2001) Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption. J Bone Miner Res 16:478-86
10. Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S et al. (1996) Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 271:12511-6
11. Durko M, Navab R, Shibata HR, Brodt P (1997) Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1. Biochim Biophys Acta 1356:271-80
12. Everts V, van der Zee E, Creemers L, Beertsen W (1996) Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem J 28:229-45
13. Fröhlich E, Schlagenhauff B, Mohrle M, Weber E, Klessen C, Rassner G (2001) Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma. Cancer 91:972-82
14. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS et al. (1996) The collagenolytic activity of cathepsin K is unique among mammalian proteases. J Biol Chem 273:32347-52
15. Gilchrest BA, Vrabel MA, Flynn E, Szabo G (1984) Selective cultivation of human melanocytes from newborn and adult epidermis. J Invest Dermatol 83:370-6
16. Goto T, Yamaza T, Tanaka T (2003) Cathepsins in the osteoclast. J Electron Microsc 52:551-8
17. Guise TA, Mohammad KS, Clines G, Stebbins EG, Wong DH, Higgins LS et al. (2006) Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res 12:6213s-6s
18. Heath DJ, Vanderkerken K, Cheng X, Gallagher O, Prideaux M, Murali R et al. (2007) An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma. Cancer Res 67:202-8
19. Hiraga T, Nakajima T, Ozawa H (1995) Bone resorption induced by a metastatic human melanoma cell line. Bone 16:349-56
20. Hofmann UB, Eggert AA, Blass K, Bröcker EB, Becker JC (2003) Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. Cancer Res 63:8221-5
21. Hofmann UB, Houben R, Bröcker EB, Becker JC (2005) Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 87:307-14
22. Hofmann UB, Westphal JR, van Muijen GN, Ruiter DJ (2000a) Matrix metalloproteinases in human melanoma. J Invest Dermatol 115:337-44
23. Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN (2000b) Expression and activation of matrix metalloproteinase-2 (MMP-2) and its colocalization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. J Pathol 191:245-56
24. Iida J, Wilhelmson KL, Price MA, Wilson CM, Pei D, Furcht LT et al. (2004) Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth. J Invest Dermatol 122:167-76
25. Itoh T, Tanioka M, Matsuda H, Nishimoto H, Yoshioka T, Suzuki R et al. (1999) Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17:177-81
26. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58:1048-51
27. Kjøller L, Engelholm LH, Hoyer-Hansen M, Dano K, Bugge TH, Behrendt N et al. (2004) uPARAP/endo180 directs lysosomal delivery and degradation of collagen IV. Exp Cell Res 293:106-16
28. Kramer RD, Marks N (1989) Identification of integrin collagen receptors on human melanoma cells. J Biol Chem 264:4684-8
29. Labrousse AL, Ntayi C, Hornebeck W, Bernard P (2004) Stromal reaction in cutaneous melanoma. Crit Rev Oncol Hematol 49:269-75
30. Lee W, Sodek J, McCulloch CA (1996) Role of integrins in regulation of collagen phagocytosis by human fibroblasts. J Cell Physiol 168:695-704
31. McQueney MS, Amegadzie BY, D'Alessio K, Hanning CR, McLaughlin MM, McNulty D et al. (1997) Autocatalytic activation of human cathepsin K. J Biol Chem 272:13955-60
32. Nikkola J, Vihinen P, Vlaykova T, Hahka-Kemppinen M, Kahari VM, Pyrhonen S (2002) High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer 97:432-8
33. Nikkola J, Vihinen P, Vuoristo MS, Kellokumpu-Lehtinen P, Kahari VM, Pyrhonen S (2005) High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin Cancer Res 11: 5158-66
34. Overall CM, Kleifeld O (2006a) Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Br J Cancer 94:941-6
35. Overall CM, Kleifeld O (2006b) Tumour microenvironment-opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6:227-39
36. Ray JM, Stetler-Stevenson WG (1995) Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J 14:908-17
37. Rieman DJ, McClung HA, Dodds RA, Hwang SM, Lark MW, Holmes S et al. (2001) Biosynthesis and processing of cathepsin K in cultured human osteoclasts. Bone 28:282-9
38. Rofstad EK, Mathiesen B, Kindem K, Galappathi K (2006) Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res 66:6699-707
39. Rünger TM, Quintanilla-Dieck MJ, Bhawan J (2007) Role of cathepsin K in the turnover of the dermal extracellular matrix during scar formation. J Invest Dermatol 127:293-7
40. Sanchez-Sweatman OH, Lee J, Orr FW, Singh G (1997) Direct osteolysis induced by metastatic murine melanoma cells: role of matrix metalloproteinases. Eur J Cancer 33:918-25
41. Schlagenhauff B, Klessen C, Teichmann-Dorr S, Breuninger H, Rassner G (1992) Demonstration of proteases in basal cell carcinomas. A histochemical study using amino acid-4-methoxy-2-naphthylamides as chromogenic substrates. Cancer 70:1133-40
42. Schultz RM, Silberman S, Persky B, Bajkowski AS, Carmichael DF (1988) Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 48:5539-45
43. Smolle J, Hofmann-Wellenhof R, Fink-Puches R (1996) Melanoma and stroma: an interaction of biological and prognostic importance. Semin Cutan Med Surg 15:326-35
44. Stabuc B, Mrevlje Z, Markovic J, Stabuc-Silih M (2006) Expression and prognostic significance of cathepsin L in early cutaneous malignant melanoma. Neoplasma 53:259-62
45. Stetler-Stevenson WG (2001) The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg Oncol Clin N Am 10:383-92
46. Troen BR (2006) The regulation of cathepsin K gene expression. Ann N Y Acad Sci 1068:165-72
47. Vaisanen A, Kallioinen M, Taskinen PJ, Turpeenniemi-Hujanen T (1998) Prognostic value of MMP-2 immunoreactive protein (72 kDa type IV collagenase) in primary skin melanoma. J Pathol 186:51-8
48. Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49:6449-65
49. Wang D, Pechar M, Li W, Kopeckova P, Brömme D, Kopecek J (2002) Inhibition of cathepsin K with lysosomotropic macromolecular inhibitors. Biochemistry 41:8849-59
50. Xia L, Kilb J, Wex H, Li Z, Lipyanski A, Breuil V et al. (1999) Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones. Biol Chem 380:679-87
51. Yamaza T, Goto T, Kamiya T, Kobayashi Y, Sakai H, Tanaka T (1998) Study of immunoelectron microscopic localization of cathepsin K in osteoclasts and other bone cells in the mouse femur. Bone 23:499-509
52. Yoon SO, Park SJ, Yun CH, Chung AS (2003) Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol 36:128-37